Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Potti

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|March 4, 2011
Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80Anil Potti, Sayan Mukherjee, Rebecca Petersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemiaArati V Rao, Peter J M Valk, Klaus H Metzeler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2009
Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancerDavid S Hsu, Chaitanya R Acharya, Bala S Balakumaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expressionCarey K Anders, David S Hsu, Gloria Broadwater, et al.
Plos One|January 3, 2008
Age-specific differences in oncogenic pathway deregulation seen in human breast tumorsCarey K Anders, Chaitanya R Acharya, David S Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancerDavid S Hsu, Bala S Balakumaran, Chaitanya R Acharya, et al.
Plos One|April 3, 2008
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancerKelly H Salter, Chaitanya R Acharya, Kelli S Walters, et al.
Nature|November 8, 2005
Oncogenic pathway signatures in human cancers as a guide to targeted therapiesAndrea H Bild, Guang Yao, Jeffrey T Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancerHolly K Dressman, Andrew Berchuck, Gina Chan, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|March 4, 2011
Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80Anil Potti, Sayan Mukherjee, Rebecca Petersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemiaArati V Rao, Peter J M Valk, Klaus H Metzeler, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2009
Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancerDavid S Hsu, Chaitanya R Acharya, Bala S Balakumaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expressionCarey K Anders, David S Hsu, Gloria Broadwater, et al.
Plos One|January 3, 2008
Age-specific differences in oncogenic pathway deregulation seen in human breast tumorsCarey K Anders, Chaitanya R Acharya, David S Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancerDavid S Hsu, Bala S Balakumaran, Chaitanya R Acharya, et al.
Plos One|April 3, 2008
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancerKelly H Salter, Chaitanya R Acharya, Kelli S Walters, et al.
Nature|November 8, 2005
Oncogenic pathway signatures in human cancers as a guide to targeted therapiesAndrea H Bild, Guang Yao, Jeffrey T Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancerHolly K Dressman, Andrew Berchuck, Gina Chan, et al.
Pageof 10